Crystal Hilger

438 total citations
13 papers, 336 citations indexed

About

Crystal Hilger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Dermatology. According to data from OpenAlex, Crystal Hilger has authored 13 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Dermatology. Recurrent topics in Crystal Hilger's work include Thyroid Cancer Diagnosis and Treatment (8 papers), Chemotherapy-related skin toxicity (3 papers) and Nausea and vomiting management (2 papers). Crystal Hilger is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (8 papers), Chemotherapy-related skin toxicity (3 papers) and Nausea and vomiting management (2 papers). Crystal Hilger collaborates with scholars based in United States, Mexico and Canada. Crystal Hilger's co-authors include Mabel Ryder, Keith C. Bible, John C. Morris, Ashish V. Chintakuntlawar, Jan L. Kasperbauer, Robert L. Foote, Nicole M. Iñiguez‐Ariza, Carin Y. Smith, Sarah M. Jenkins and Kandelaria M. Rumilla and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Thyroid.

In The Last Decade

Crystal Hilger

13 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Crystal Hilger United States	10	208	146	88	60	42	13	336
Tommaso Porcelli Italy	11	278 1.3×	77 0.5×	39 0.4×	39 0.7×	20 0.5×	31	412
Meredith Kato United States	8	282 1.4×	59 0.4×	212 2.4×	27 0.5×	50 1.2×	17	415
Nami Takada Japan	11	160 0.8×	64 0.4×	102 1.2×	26 0.4×	31 0.7×	24	277
Maryse Brassard France	7	320 1.5×	70 0.5×	123 1.4×	37 0.6×	17 0.4×	10	390
Crystal Kamilaris United States	7	126 0.6×	80 0.5×	133 1.5×	33 0.6×	10 0.2×	14	323
C J Lips Netherlands	8	90 0.4×	159 1.1×	41 0.5×	25 0.4×	21 0.5×	9	390
Ferhunde Dizdaroğlu Türkiye	11	64 0.3×	90 0.6×	155 1.8×	54 0.9×	37 0.9×	18	309
Silvia Pecchio Italy	8	53 0.3×	143 1.0×	49 0.6×	43 0.7×	72 1.7×	13	306
Maria Boudina Greece	12	245 1.2×	48 0.3×	150 1.7×	49 0.8×	25 0.6×	27	333
Naoya Matoba Japan	9	155 0.7×	148 1.0×	100 1.1×	57 0.9×	57 1.4×	24	338

Countries citing papers authored by Crystal Hilger

Since Specialization

Citations

This map shows the geographic impact of Crystal Hilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crystal Hilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crystal Hilger more than expected).

Fields of papers citing papers by Crystal Hilger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crystal Hilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crystal Hilger. The network helps show where Crystal Hilger may publish in the future.

Co-authorship network of co-authors of Crystal Hilger

This figure shows the co-authorship network connecting the top 25 collaborators of Crystal Hilger. A scholar is included among the top collaborators of Crystal Hilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crystal Hilger. Crystal Hilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Morris, John C., Aditi Kumar, Ashish V. Chintakuntlawar, et al.. (2024). Pemetrexed‐carboplatin salvage therapy in advanced thyroid cancers. Head & Neck. 47(3). 813–821. 1 indexed citations

Morris, John C., et al.. (2023). Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 34(1). 70–81. 13 indexed citations

Fuentes, Harry E, Jun Yin, Erik Asmus, et al.. (2022). Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas. Journal of the Endocrine Society. 6(5). bvac044–bvac044. 11 indexed citations

Iñiguez‐Ariza, Nicole M., Sina Jasim, Mabel Ryder, et al.. (2020). Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy. The Journal of Clinical Endocrinology & Metabolism. 105(7). e2346–e2357. 13 indexed citations

Miller, Kevin C., Ashish V. Chintakuntlawar, Crystal Hilger, et al.. (2020). Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma. Journal of the Endocrine Society. 4(7). bvaa069–bvaa069. 13 indexed citations

Chintakuntlawar, Ashish V., Jun Yin, Robert L. Foote, et al.. (2019). A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. Thyroid. 29(11). 1615–1622. 57 indexed citations

Iñiguez‐Ariza, Nicole M., Mabel Ryder, Crystal Hilger, & Keith C. Bible. (2017). Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer. Thyroid. 27(7). 923–927. 28 indexed citations

Iñiguez‐Ariza, Nicole M., Keith C. Bible, John C. Morris, et al.. (2017). NTRK1-3 point mutations in poor prognosis thyroid cancers.. Journal of Clinical Oncology. 35(15_suppl). 6087–6087. 1 indexed citations

Chintakuntlawar, Ashish V., Kandelaria M. Rumilla, Carin Y. Smith, et al.. (2017). Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism. 102(6). 1943–1950. 103 indexed citations

10.

Jasim, Sina, Nicole M. Iñiguez‐Ariza, Crystal Hilger, et al.. (2017). Optimizing Lenvatinib Therapy in Patients with Metastatic Radioactive Iodine-resistant Differentiated Thyroid Cancers. Endocrine Practice. 23(10). 1254–1261. 23 indexed citations

11.

Hegerova, Livia, Alexis D. Leal, Drew K. Seisler, et al.. (2014). An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy. Supportive Care in Cancer. 23(1). 55–59. 26 indexed citations

12.

Leal, Alexis D., Kunal C. Kadakia, Crystal Hilger, et al.. (2014). Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy. Supportive Care in Cancer. 22(5). 1313–1317. 44 indexed citations

13.

Leal, Alexis D., Kunal C. Kadakia, Crystal Hilger, et al.. (2013). Fosaprepitant-induced phlebitis: A focus on patients receiving doxorubicin/cyclophosphamide therapy.. Journal of Clinical Oncology. 31(15_suppl). e20605–e20605. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact